In a filing, Axsome Therapeutics Inc revealed its Director Saad Mark E unloaded Company’s shares for reported $1.01 million on Sep 11 ’24. In the deal valued at $91.31 per share,11,016 shares were sold. As a result of this transaction, Saad Mark E now holds 10,002 shares worth roughly $0.85 million.
Then, Saad Mark E bought 11,016 shares, generating $1,005,843 in total proceeds.
Before that, Jacobson Mark L. sold 47,739 shares. Axsome Therapeutics Inc shares valued at $4,022,488 were divested by the Chief Operating Officer at a price of $84.26 per share. As a result of the transaction, Jacobson Mark L. now holds 5,783 shares, worth roughly $0.49 million.
Mizuho reiterated its Axsome Therapeutics Inc [AXSM] rating to an Outperform in a research note published on December 31, 2024; the price target was $122. A number of analysts have revised their coverage, including Wells Fargo’s analysts, who began to cover the stock in early September with a ‘”an Overweight”‘ rating. BofA Securities also remained covering AXSM and has increased its forecast on August 06, 2024 with a “Buy” recommendation from previously “Neutral” rating. Needham started covering the stock on July 22, 2024. It rated AXSM as “a Buy”.
Price Performance Review of AXSM
On Monday, Axsome Therapeutics Inc [NASDAQ:AXSM] saw its stock fall -1.53% to $85.13. Over the last five days, the stock has lost -1.81%. Axsome Therapeutics Inc shares have risen nearly 0.61% since the year began. Nevertheless, the stocks have risen 3.83% over the past one year. While a 52-week high of $105.00 was reached on 01/02/25, a 52-week low of $64.11 was recorded on 01/06/25. SMA at 50 days reached $92.70, while 200 days put it at $84.35.
Levels Of Support And Resistance For AXSM Stock
The 24-hour chart illustrates a support level at 83.74, which if violated will result in even more drops to 82.36. On the upside, there is a resistance level at 86.80. A further resistance level may holdings at 88.48. The Relative Strength Index (RSI) on the 14-day chart is 37.32, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.65, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 49.84%. Stochastics %K at 53.32% indicates the stock is a holding.
How much short interest is there in Axsome Therapeutics Inc?
A steep rise in short interest was recorded in Axsome Therapeutics Inc stocks on 2024-12-13, dropping by -1.17 million shares to a total of 6.52 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 7.69 million shares. There was a decline of -17.98%, which implies that there is a negative sentiment for the stock.
